These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 26386135)

  • 21. Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia.
    Maguire Á; Hargreaves A; Gill M
    Nutr Neurosci; 2020 Oct; 23(10):756-769. PubMed ID: 30537908
    [No Abstract]   [Full Text] [Related]  

  • 22. Major channels involved in neuropsychiatric disorders and therapeutic perspectives.
    Imbrici P; Camerino DC; Tricarico D
    Front Genet; 2013; 4():76. PubMed ID: 23675382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voltage-gated calcium channels in genetic diseases.
    Bidaud I; Mezghrani A; Swayne LA; Monteil A; Lory P
    Biochim Biophys Acta; 2006 Nov; 1763(11):1169-74. PubMed ID: 17034879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unravelling the pathophysiology of calcium channel mutations causing neurological disorders.
    Fontaine B; Tabti N
    Brain; 2000 Mar; 123 Pt 3():423-4. PubMed ID: 10686168
    [No Abstract]   [Full Text] [Related]  

  • 25. [The alpha2delta subunit of the voltage-dependent calcium channel. A new pharmaceutical target for psychiatry and neurology].
    Wedekind D; Bandelow B
    Nervenarzt; 2005 Jul; 76(7):888-91. PubMed ID: 15952008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders.
    Carter CJ
    Pathog Dis; 2013 Dec; 69(3):240-61. PubMed ID: 23913659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Single-Nucleotide Polymorphisms in Human Voltage-Gated Ion Channels.
    Nastou KC; Batskinis MA; Litou ZI; Hamodrakas SJ; Iconomidou VA
    J Proteome Res; 2019 May; 18(5):2310-2320. PubMed ID: 30908064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Drosophila calcium channel alpha1 subunit gene maps to a genetic locus associated with behavioral and visual defects.
    Smith LA; Wang X; Peixoto AA; Neumann EK; Hall LM; Hall JC
    J Neurosci; 1996 Dec; 16(24):7868-79. PubMed ID: 8987815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in psychiatric and neurodevelopmental disorders.
    Xu B; Karayiorgou M; Gogos JA
    Brain Res; 2010 Jun; 1338():78-88. PubMed ID: 20388499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRPC Channels and Mental Disorders.
    Griesi-Oliveira K; Suzuki AM; Muotri AR
    Adv Exp Med Biol; 2017; 976():137-148. PubMed ID: 28508319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From genes to effective drugs for neurological and psychiatric diseases.
    Hefti F
    Trends Pharmacol Sci; 2001 Apr; 22(4):159-60. PubMed ID: 11282404
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.
    Pasquini S; Contri C; Merighi S; Gessi S; Borea PA; Varani K; Vincenzi F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecule-based genetic association approach implicates a range of voltage-gated calcium channels associated with schizophrenia.
    Li W; Fan CC; Mäki-Marttunen T; Thompson WK; Schork AJ; Bettella F; ; Djurovic S; Dale AM; Andreassen OA; Wang Y
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):454-467. PubMed ID: 29704319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Channelopathies: ion channel defects linked to heritable clinical disorders.
    Felix R
    J Med Genet; 2000 Oct; 37(10):729-40. PubMed ID: 11015449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation within voltage-gated calcium channel genes and antipsychotic treatment response in a South African first episode schizophrenia cohort.
    O'Connell KS; McGregor NW; Malhotra A; Lencz T; Emsley R; Warnich L
    Pharmacogenomics J; 2019 Feb; 19(1):109-114. PubMed ID: 30032160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperactivation of L-type voltage-gated Ca2+ channels in Caenorhabditis elegans striated muscle can result from point mutations in the IS6 or the IIIS4 segment of the α1 subunit.
    Lainé V; Ségor JR; Zhan H; Bessereau JL; Jospin M
    J Exp Biol; 2014 Nov; 217(Pt 21):3805-14. PubMed ID: 25214488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.
    Johannessen Landmark C
    CNS Drugs; 2008; 22(1):27-47. PubMed ID: 18072813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DRD2 gene in psychiatric and neurological disorders and its phenotypes.
    Noble EP
    Pharmacogenomics; 2000 Aug; 1(3):309-33. PubMed ID: 11256581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative splicing: functional diversity among voltage-gated calcium channels and behavioral consequences.
    Lipscombe D; Andrade A; Allen SE
    Biochim Biophys Acta; 2013 Jul; 1828(7):1522-9. PubMed ID: 23022282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.